نتائج البحث 131-140 من 9854 لعملية البحث عن Two-phase
The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...
... Phase 2 part to further assess the effectiveness ... The purpose of this study is to compare the effects, good and/or bad of two treatment methods on subjects and ...
Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel-arm study of avelumab in ...
... (2) Cohort 2 focuses on primary or secondary myelofibrosis ... Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase ...
... Phase 2 dose (RP2D), as well as to evaluate preliminary effectiveness. A ... BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) ...
... phase 2 dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma.
The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma ...
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients ... Study B9991011 is a multi-center, international, randomized, open label, 2 ...
The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 ... stage III-IV squamous cell head and neck cancer.
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.